Hepatitis C in adults and adolescents with inherited coagulation disorders in the United States: results of a randomized, multicenter trial of combination therapy (interferon α-2B + ribavirin): Michael W Fried, University of North Carolina, Chapel Hill, Chapel Hill, NC; Joy Peter, Emory University, Atlanta, GA; Keith Hoots, University of Texas, Houston, TX; Paul Gaglio, Tulane University, New Orleans, LA; D Talbut, NW Ohio Hemophilia Center, Toledo, OH; P Davis, Children's Healthcare, Atlanta, GA; Fred Rickles, George Washington University Hospital, Washington, DC; Thomas Abshire, Emory University, Atlanta, GA; Hemophilia Hepatitis Therapy Group, University of North Carolina, Chapel Hill, NC